Executive function and depressive symptoms of retardation in nonelderly stroke patients

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Citação
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, v.36, n.6, p.636-647, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The depression-executive dysfunction syndrome, a late-onset depression of vascular origin with executive dysfunction and psychomotor retardation, has also been described after stroke. We verified whether this syndrome also occurs in nonelderly stroke patients by investigating the association between domains of depressive symptoms with executive functions in 87 first-ever ischemic stroke patients. The retardation domain of the 31-item Hamilton Rating Scale for Depression was associated with decreased performance on verbal fluency (assessed with FAS). The association was maintained for younger patients (aged <60 years) after adjusting for confounders. This result supports the clinical presentation of depression-executive dysfunction syndrome in younger stroke patients. Confirmation of this finding, its neural correlates, and clinical implication deserve further investigation.
Palavras-chave
Executive functions, Depressive symptoms, Stroke, Neuropsychological tests, Vascular depression
Referências
  1. Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P98, DOI 10.1176/appi.ajgp.10.1.98
  2. Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929
  3. Alexopoulos GS, 2001, AM J GERIAT PSYCHIAT, V9, P22, DOI 10.1176/appi.ajgp.9.1.22
  4. Alexopoulos GS, 1997, AM J PSYCHIAT, V154, P562
  5. Alves TCTF, 2007, PSYCHOSOMATICS, V48, P22, DOI 10.1176/appi.psy.48.1.22
  6. *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT
  7. Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994
  8. Benton AL, 1989, MULTILINGUAL APHASIA
  9. BOLLAWILSON K, 1989, AM J PSYCHIAT, V146, P627
  10. Bour A, 2011, INT J GERIATR PSYCH, V26, P679, DOI 10.1002/gps.2581
  11. Brandao E., 1997, THESIS SAO PAULO PON
  12. Brunoni AR, 2013, PSYCHONEUROENDOCRINO, V38, P58, DOI 10.1016/j.psyneuen.2012.04.020
  13. Bueno VF, 2011, NEUROCASE, V17, P318, DOI 10.1080/13554794.2010.509319
  14. Charchat-Fichman H, 2009, ARQ NEURO-PSIQUIAT, V67, P445, DOI 10.1590/S0004-282X2009000300014
  15. Ducan M. T., 2006, J BRAS PSIQUIAT, V55, P42
  16. EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813
  17. Finkenzeller W, 2009, NERVENARZT, V80, P805, DOI 10.1007/s00115-008-2649-1
  18. First MB, 1995, STRUCTURED CLIN INTE
  19. Fossati P, 2002, J AFFECT DISORDERS, V68, P261, DOI 10.1016/S0165-0327(00)00362-1
  20. Friston KJ, 1996, CEREB CORTEX, V6, P156, DOI 10.1093/cercor/6.2.156
  21. HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
  22. Hobson P, 2010, J STROKE CEREBROVASC, V19, P382, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.006
  23. House A, 2001, STROKE, V32, P696
  24. Iosifescu DV, 2005, PSYCHOSOM MED, V67, P703, DOI 10.1097/01.psy.0000170338.75346.d0
  25. Iosifescu DV, 2006, BRIT J PSYCHIAT, V188, P180, DOI 10.1192/bjp.188.2.180
  26. Jamerson Brenda D, 2003, Psychopharmacol Bull, V37, P67
  27. Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134
  28. Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748
  29. Kauhanen ML, 1999, STROKE, V30, P1875
  30. Kimura M, 2002, INT CLIN PSYCHOPHARM, V17, P121, DOI 10.1097/00004850-200205000-00005
  31. Kimura M, 2000, STROKE, V31, P1482
  32. Kotila M, 1999, EUR J NEUROL, V6, P309, DOI 10.1046/j.1468-1331.1999.630309.x
  33. Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497
  34. Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262
  35. Lezak M.D., 1995, NEUROPSYCHOLOGICAL A
  36. Lockwood KA, 2002, AM J PSYCHIAT, V159, P1119, DOI 10.1176/appi.ajp.159.7.1119
  37. McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063
  38. Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2
  39. Melkas S, 2010, AM J GERIAT PSYCHIAT, V18, P1007, DOI 10.1097/JGP.0b013e3181d695d7
  40. Meusel LAC, 2013, PSYCHIAT RES-NEUROIM, V214, P142, DOI 10.1016/j.pscychresns.2013.06.007
  41. Murata Y, 2000, AM J GERIAT PSYCHIAT, V8, P310, DOI 10.1176/appi.ajgp.8.4.310
  42. Naarding P, 2003, INT J GERIATR PSYCH, V18, P325, DOI 10.1002/gps.831
  43. Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157
  44. Narushima K, 2007, BRIT J PSYCHIAT, V190, P260, DOI 10.1192/bjp.bp.106.025064
  45. Nyenhuis DL, 2004, CLIN NEUROPSYCHOL, V18, P41, DOI 10.1080/13854040490507145
  46. Nys GMS, 2005, J INT NEUROPSYCH SOC, V11, P795, DOI 10.1017/S1355617705050952
  47. Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464
  48. Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005
  49. Nys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031
  50. O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3
  51. Papakostas GI, 2005, PSYCHIAT RES-NEUROIM, V140, P301, DOI 10.1016/j.pscychresns.205.09.001
  52. Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x
  53. Pohjasvaara T, 1997, STROKE, V28, P785
  54. Pohjasvaara T, 1998, STROKE, V29, P2311
  55. Porter RJ, 2013, AUST NZ J PSYCHIAT, V47, P1165, DOI 10.1177/0004867413502090
  56. Prokopenko SV, 2013, J NEUROL SCI, V325, P148, DOI 10.1016/j.jns.2012.12.024
  57. Rasquin SMC, 2009, NEUROPSYCHOL REHABIL, V19, P208, DOI 10.1080/09602010802091159
  58. Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142
  59. Rorden C, 2000, BEHAV NEUROL, V12, P191
  60. Rorden C., 2005, MRICRO SOFTWARE
  61. Sato S, 2006, PSYCHIAT CLIN NEUROS, V60, P584, DOI 10.1111/j.1440-1819.2006.01562.x
  62. Schramke CJ, 1998, J CLIN EXP NEUROPSYC, V20, P723, DOI 10.1076/jcen.20.5.723.1117
  63. Sheline YI, 2010, ARCH GEN PSYCHIAT, V67, P277, DOI 10.1001/archgenpsychiatry.2009.204
  64. Spreen O, 1991, COMPENDIUM NEUROPSYC
  65. Statistical Parametric Mapping (SPM5), 2005, COMPUTER SOFTWARE
  66. Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651
  67. Talairach J, 1988, COPLANAR STEREOTAXIC
  68. TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202
  69. Taylor WD, 2003, ARCH GEN PSYCHIAT, V60, P1090, DOI 10.1001/archpsyc.60.11.1090
  70. Terroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242
  71. Terroni LDN, 2009, REV BRAS PSIQUIATR, V31, P202, DOI 10.1590/S1516-44462009000300004
  72. Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4
  73. Trivedi MH, 2013, AM J PSYCHIAT, V170, P633, DOI 10.1176/appi.ajp.2012.12020250
  74. VanEssen DC, 1997, J NEUROSCI, V17, P7079
  75. Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788
  76. Vataja R, 2005, AM J GERIAT PSYCHIAT, V13, P99, DOI 10.1176/appi.ajgp.13.2.99
  77. Verdelho A, 2004, NEUROLOGY, V62, P905
  78. Wechsler D., 1981, WECHSLER ADULT INTEL
  79. Williamson J, 2010, J CLIN EXP NEUROPSYC, V32, P673, DOI 10.1080/13803390903427406
  80. World Health Organization, 1989, STROKE, V20, P1407
  81. Yochim BP, 2006, J CLIN EXP NEUROPSYC, V28, P495, DOI 10.1080/13803390590949322
  82. Zhou B, 2010, J ALZHEIMERS DIS, V22, P673, DOI 10.3233/JAD-2010-100318
  83. Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028